Phase-III Clinical Trial of Adjuvant FAM2 (5-FU, Adriamycin and Mitomycin C) vs Control in Resectable Gastric Cancer: A Study of the EORTC Gastrointestinal Tract Cancer Cooperative Group
M. Lise
◽
D. Nitti
◽
M. Buyse
◽
G. Cartei
◽
A. Fornasiero
◽
...